Skip to main content

BARCLAYS PLC

Position in JANX — Janux Therapeutics, Inc.

CIK 312069 LONDON, X0

Position in JANX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$778,232
-$2,274,783 QoQ
Shares Held
55,988
-74.7% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JANX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. JANX ranks #115 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in JANX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $778,232 55,988
2025-12-31 $3,053,015 221,233
2025-09-30 $3,519,945 144,024
2025-06-30 $3,057,076 132,341
2025-03-31 $1,829,682 67,766
2024-12-31 $14,132,953 263,970
2024-09-30 $7,907,591 174,061
2024-06-30 $1,222,266 29,178
2024-03-31 $583,575 15,500
2023-12-31 $512,057 47,722
2023-09-30 $180,653 17,922
2023-06-30 $65,035 5,479
2023-03-31 $107,738 8,904
2022-12-31 $60,687 4,608
2022-09-30 $9,857 728
2022-06-30 $10,500 860
2022-03-31 $42,274 2,948